• 中国核心期刊(遴选)数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

• 药品评价-安全性研究 • 上一篇    下一篇

102例药品不良反应/事件分析

黄斌   

  1. 遵义医学院第五附属(珠海)医院
  • 收稿日期:2018-05-16 修回日期:2018-07-13 出版日期:2018-08-25 发布日期:2018-08-25
  • 基金资助:
    贵州省科学技术基金资助项目(黔科合LH字[2014]7560号)*

Analysis of 102 Cases of ADR/ADE Reports

huangbin   

  1. the fifith affiliated hospital of Zunyi medical college
  • Received:2018-05-16 Revised:2018-07-13 Online:2018-08-25 Published:2018-08-25

摘要: 目的:收集我院报告的药品不良反应/事件(ADR/ADE),分析其特点及原因并提出预防对策,促进临床合理用药。方法:采用回顾性分析的方法,对我院2017年1-12月期间上报的102例ADR/ADE报告进行分析。结果: 102例ADR/ADE中,女性略多于男性(58/44),年龄主要集中在>60岁(占31.37%);其中新的严重的ADR/ADE有6例(占5.88%);引起ADR/ADE的主要是静脉滴注给药(占50.00%);共涉及8类药,62个品种,其中抗感染类药最多(占35.29%)。ADR/ADE主要累及消化系统(占33.60%)、皮肤及其附件(占21.60%);不合理用药40例(占39.22%)。结论:引起ADR/ADE发生的因素,与不合理用药有关,同时与患者本身、药物本身以及药物使用不当等因素有关,临床加强ADR/ADE的监测以及合理用药是降低不良反应发生的关键,确保临床用药安全有效。

Abstract: Objective: Cases of ADR/ADE reports of our hospital were collected,to analyze the characteristics, causes of the cases and the preventive measures of the adverse drug reaction/event(ADR/ADE),and in order to provide scientific basis for clinical rational use of drugs. Methods: 102 cases of ADR/ADE collected by our hospital were analyzed statistically and retrospectively. Results:Among 102 cases of ADR/ADE reports, there were more females than males(58/44), the number of patients aged >60 years old took the lead(31.37%). There were 6 new and serious ADR/ADE cases(5.88%). The most common ADR/ADE were induced by intravenous infusion(50. 00%). A total of 8 kinds of drugs were involved, including 62 categories, among which anti-infective drugs dominated the first place(35.29%). ADR/ADE mainly involved digestive system damage(33.60%), skin and its accessories damage (21.60%). The were 40 cases of irrational use of medication(39.22%). Conclusion: The factors which lead to the ADR/ADE include irrational use of medication, patients, drugs and inappropriate usage. We should enhance the monitoring of ADR/ADE, promote the rational drug use in clinic, so as to improve the security and effectiveness of clinical medication.